Cargando…

Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker of Tubular Damage in Diabetic Nephropathy

BACKGROUND: An increase in neutrophil gelatinase-associated lipocalin (NGAL) indicates tubular injury. Diabetic nephropathy causes typical changes in the kidney, characterized by glomerulosclerosis and eventual tubular damage. We validated the usefulness of plasma NGAL (pNGAL) as a biomarker of tubu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, So Young, Jeong, Tae-Dong, Lee, Woochang, Chun, Sail, Sunwoo, Sung, Kim, Soon Bae, Min, Won-Ki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056390/ https://www.ncbi.nlm.nih.gov/pubmed/30027695 http://dx.doi.org/10.3343/alm.2018.38.6.524

Ejemplares similares

Evaluation of Neutrophil Gelatinase-associated Lipocalin and Cystatin C as Early Markers of Diabetic Nephropathy
por: Siddiqi, Zeba, et al.
Publicado: (2017)

The role of neutrophil-gelatinase-associated lipocalin in early diagnosis of contrast nephropathy
por: Khatami, M. R., et al.
Publicado: (2015)

Neutrophil gelatinase-associated lipocalin as a marker of tubular damage appears to be unrelated to fractional excretion of sodium as a marker of tubular function in septic patients, with or without AKI
por: Glassford, NJ, et al.
Publicado: (2011)

Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy
por: Park, Ga-Young, et al.
Publicado: (2015)

The origin of plasma neutrophil gelatinase-associated lipocalin in cardiac surgery
por: Passov, Arie, et al.
Publicado: (2019)

Plasma neutrophil gelatinase-associated lipocalin and kidney graft outcome
por: Kremer, Daan, et al.
Publicado: (2021)

Neutrophil gelatinase–associated lipocalin as a biomarker of nephropathy in sickle cell disease
por: Marouf, Rajaa, et al.
Publicado: (2021)

Association of peripheral blood neutrophil gelatinase‐associated lipocalin levels with bone marrow neutrophil gelatinase‐associated lipocalin levels and neutrophil count in hematologic malignancy
por: Cho, Chi‐Hyun, et al.
Publicado: (2019)

Plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomography
por: Filiopoulos, Vassilis, et al.
Publicado: (2013)

Diagnostic value of neutrophil gelatinase-associated lipocalin in diabetic nephropathy: a meta-analysis
por: Chen, Bin, et al.
Publicado: (2019)

Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease
por: Troia, Roberta, et al.
Publicado: (2022)

Expression and Function of Interleukin-1β-Induced Neutrophil Gelatinase-Associated Lipocalin in Renal Tubular Cells
por: Konno, Tadayoshi, et al.
Publicado: (2016)

Combination of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase-9 are biomarkers for the detection of colon tubular adenocarcinoma
por: Yuan, Jun-Hua, et al.
Publicado: (2021)

Plasma and urine neutrophil gelatinase-associated lipocalin as markers of acute kidney injury in critically ill adults
por: Matsa, R, et al.
Publicado: (2012)

Expression of Neutrophil Gelatinase-Associated Lipocalin in Calcium-Induced Keratinocyte Differentiation
por: Lee, Jeung-Hoon, et al.
Publicado: (2008)

Neutrophil gelatinase-associated lipocalin as a predictor of adverse renal outcomes in immunoglobulin A nephropathy
por: Ma, Seong Kwon
Publicado: (2015)

Interleukin 18 and neutrophil-gelatinase associated lipocalin in assessment of the risk of contrast-induced nephropathy in children
por: Lichosik, Marianna, et al.
Publicado: (2016)

Plasma and urine neutrophil gelatinase-associated lipocalin in septic and nonseptic ICU patients
por: Vrettou, CS, et al.
Publicado: (2012)

Neutrophil Gelatinase-Associated Lipocalin Levels During Pneumoperitoneum
por: Kiseli, Mine, et al.
Publicado: (2017)

Neutrophil gelatinase–associated lipocalin as an immunomodulator in endocrine hypertension
por: Araos, Patricio, et al.
Publicado: (2022)

Monomeric neutrophil gelatinase associated lipocalin is associated with tubulointerstitial damage in chronic kidney disease
por: Nickolas, Thomas L., et al.
Publicado: (2012)

Neutrophil Gelatinase-associated Lipocalin: As a Predictor of Early Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Kaul, A., et al.
Publicado: (2018)

Elevated plasma level of neutrophil gelatinase-associated lipocalin (NGAL) in patients with breast cancer
por: Wei, Ching-Ting, et al.
Publicado: (2021)

Plasma Neutrophil Gelatinase-Associated Lipocalin Is Useful for Predicting Mortality in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2021)

Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker for Prediction of 3-Month Graft Survival after Kidney Transplantation
por: Jafari, A., et al.
Publicado: (2017)

Neutrophil gelatinase-associated lipocalin in ICU patients developing oliguria
por: Roman, A, et al.
Publicado: (2011)

Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer
por: Candido, Saverio, et al.
Publicado: (2014)

Urinary Excretion of Neutrophil Gelatinase-Associated Lipocalin in Diabetic Rats
por: Arellano-Buendía, Abraham Said, et al.
Publicado: (2014)

Role of neutrophil gelatinase-associated lipocalin in renal cell carcinoma
por: Che, Kai, et al.
Publicado: (2021)

The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL)
por: Romejko, Katarzyna, et al.
Publicado: (2023)

Evaluation of the Optimal Neutrophil Gelatinase-Associated Lipocalin Value as a Screening Biomarker for Urinary Tract Infections in Children
por: Kim, Bo Hyun, et al.
Publicado: (2014)

Expression of neutrophil gelatinase-associated lipocalin in low osmolar contrast-induced nephropathy in rats and the effect of N-acetylcysteine
por: Li, Wen-Hua, et al.
Publicado: (2016)

Neutrophil gelatinase-associated lipocalin as an early predictor of contrast-induced nephropathy following endovascular therapy for arteriosclerosis obliterans
por: Liu, Zhenjie, et al.
Publicado: (2020)

Predictive value of cystatin C and neutrophil gelatinase-associated lipocalin in contrast-induced nephropathy: A meta-analysis
por: He, Yi, et al.
Publicado: (2020)

Urinary neutrophil gelatinase‐associated lipocalin in dogs with stable or progressive kidney disease
por: Kim, Yoojin M., et al.
Publicado: (2019)

Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure
por: Breidthardt, Tobias, et al.
Publicado: (2012)

Dialysis with high-flux membranes significantly affects plasma levels of neutrophil gelatinase-associated lipocalin
por: Donadio, Carlo
Publicado: (2016)

Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease
por: Li, Chao, et al.
Publicado: (2019)

Serum neutrophil gelatinase-associated lipocalin as a marker of kidney function in pregnancy – useful or doubtful?
por: Małyszko, Jacek S., et al.
Publicado: (2010)

Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential?
por: McLean, M H, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bu0g88naehrp6c56lkdmn2p1i1